MCL-1 amplification and overexpression is associated with the proliferation, drug resistance and inferior prognosis in various tumors including ESCC (61, 62), and inhibition of CPEB4-mediated MCL-1 translation can reverse the resistance to cisplatin in ESCC (63). The gene discussed is MCL1; the disease is esophageal squamous cell carcinoma.